
Opinion|Videos|August 18, 2023
The Evolving Treatment Paradigm for Plaque Psoriasis
Author(s)Alexandra K. Golant, MD , Mona Shahriari, MD, FAAD
Experts in dermatology comment on the impact of both roflumilast and tapinarof on the treatment of plaque psoriasis.
Advertisement
Episodes in this series

Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Top 5 Articles of the Week: November 30-December 5
3
The Weekly Roundup: December 1-5
4
ICYMI: First Patient Dosed in Global Phase 2 Study of Oral TYK2 Inhibitor Soficitinib for PN
5




















